GENE ONLINE|News &
Opinion
Blog

Schizophrenia
Otsuka and Lundbeck’s Treatment for Schizophrenia and Bipolar I NDA Accepted by the FDA
2022-09-13
Karuna Therapeutics Announces Topline Results from Schizophrenia Therapy Clinical Trial
2022-08-08
BioXcel Gets FDA Nod for First Oral Sublingual Film for Schizophrenia Treatment
2022-04-08
Transcriptional Programs Uncovering the Genetic Causes of Psychiatric Disorders
2022-03-01
FDA Approves Drug for Schizophrenia in Pediatric Patients
2022-01-10
Janssen’s Long-acting Schizophrenia Drug Notches FDA Approval
2021-09-02
Alkermes Overcomes Regulatory Setbacks to Snag FDA Approval for Schizophrenia Drug
2021-06-01
Neurocrine, Takeda Look to Build on Positives Post Luvadaxistat’s Schizophrenia Trial Failure
2021-03-03
SECUADO – The Hope to Enhance Schizophrenia Patients’ Quality of Life
2019-11-14
Single neurons responsible for error detection and adjustment found
2019-01-03
LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!